Determining the Mechanisms of Loss of CAR T Cell Persistence
NCT ID: NCT05809284
Last Updated: 2024-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2023-10-18
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL
NCT05571540
CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）
NCT03544021
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
NCT03984968
Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study
NCT07236203
Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia
NCT02810223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Written informed consent
Exclusion Criteria
2. Any reason that in the opinion of the investigator, patients won't be able to adhere to the protocol
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Persis Amrolia, BSc,MBBS,PhD
Role: STUDY_CHAIR
UCL Institute of Child Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Great Ormond Street Hospital
London, , United Kingdom
University College London Hospital
London, , United Kingdom
Royal Manchester Children's Hospital
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Persis Amrolia
Role: primary
Rachael Hough
Role: primary
Denise Bonney
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCL/156503
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.